| |
|
|
|
Tracon Pharma  
|
|
10.61 0.47 (0.05%) |
01-22 16:00 |
|
Open: |
10.05 |
Pre close: |
10.14 |
Target:
|
14.25
|
|
High: |
10.77 |
Low: |
10.05 |
Resistance:
|
12.20
14.25
|
|
Volume: |
310,582 |
Market Cap: |
154M |
Support:
|
9.26
7.45
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
10.43
 |
MACD |
MACD(12,26):
|
0.51 |
|
MA(20): |
10.24  |
Signal(12,26,9): |
0.59 |
|
MA(100): |
6.87 |
Stochastic Oscillator |
%K(14,3):
|
38.10 |
|
MA(250): |
4.05 |
%D(3): |
44.28 |
|
Average Volume(K) |
3-Month: |
82090
|
52-Week |
High:
|
12.20 |
|
10-Days: |
56303 |
Low: |
0.95 |
|
RSI |
RSI(14):
|
56.28 |
Change(%): |
169.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.600 |
Return on Equity (ttm) |
-168.0 |
Shares Out. (M) |
14.53 |
|
EPS Est. Current Year |
-1.570 |
Return on Assets (ttm) |
-40.2 |
Shares Float (M) |
8.16 |
|
EPS Est. Next Year |
-1.830 |
PEG Ratio |
0.00 |
% Held by Insiders |
2.02 |
|
EPS Est. Next Quarter |
-0.490 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
38.55 |
|
Forward EPS |
-7.470 |
Gross Profit (p.s.) |
-1.000 |
Shares Short (K) |
179 |
|
Book Value (p.s.) |
1.130 |
EBITDA (p.s.) |
-1.090 |
P/E |
-4.08 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
9.39 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-17.66 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-11.21 |
P/CF |
-8.73 |
|
|
|
|
|
|
